Medication info
Arafen Semi Tablet

Arafen Semi Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›18.75mg / 1 tabletAcetaminophen›162.5mg / 1 tablet
Manufacturer / importer
Celltrion Pharm, Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200707943 · Notified 2007.07.10 · Insurance code 693900270

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
The dose should be adjusted according to the severity of the patient's pain and response to treatment. Administer the lowest effective dose for the shortest possible period. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval for patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years or older: The recommended initial dose is 4 tablets. Thereafter, allow at least 6 hours between doses and do not exceed 16 tablets per day.

Ingredients

Manufacturer
Celltrion Pharm, Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

The dose should be adjusted according to the severity of the patient's pain and response to treatment. Administer the lowest effective dose for the shortest possible period. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval for patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years or older: The recommended initial dose is 4 tablets. Thereafter, allow at least 6 hours between doses and do not exceed 16 tablets per day.

Precautions

This medicine may affect the liver, so individuals who consume large amounts of alcohol daily must consult a doctor or pharmacist before taking it. If a rash or allergic reaction appears on the skin during the use of this medication, discontinue use immediately and consult a healthcare professional. Due to the risk of seizures, caution is advised if there is a history of seizures or when taking medications that increase the risk of seizures. Patients with severe respiratory conditions may experience respiratory depression while taking this medication, so it should be administered under medical supervision. Taking this medication with alcohol or other central nervous system depressants may cause severe drowsiness or impaired breathing, so co-administration should be avoided or monitored closely. Patients with head injuries or brain disorders should be cautious, as their symptoms may worsen when taking this medication. This medication can cause dependency; therefore, dosages and duration of use must be adjusted according to doctor's advice if used long-term. Patients with poor liver function must consult a doctor before taking this medication, and dose adjustments may be necessary. This medication should not be administered to children under 12 years or specific post-surgical pediatric patients, and caution is required when used in children and adolescents. If pregnant or breastfeeding, it is essential to consult a doctor before taking this medication, and breastfeeding mothers should avoid use if possible. Drowsiness or dizziness may occur when driving or operating machinery while taking this medication, so caution is necessary. Do not exceed the prescribed dosage, and be careful not to take other medications containing acetaminophen or tramadol together. Severe side effects may occur from overdose, so strict adherence to the dosing is required, and if suspected, immediate medical attention is needed. Store this medication in a safe place out of reach of children to prevent accidental ingestion.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, appetite loss, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, neuroexcitation, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, drowsiness, sensory loss, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, respiratory distress, dry throat, elevated liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, weakness, chest pain, emotional abnormalities, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, hot flashes, weight loss, increased serum creatinine, anaphylactic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, impact on emotional instability, delirium, suicidal thoughts, muscle hypertonicity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prothrombin time elongation, thrombocytopenia, agranulocytosis, blood disorders, thrombocytopenia, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, dry mouth, dysphagia, tongue swelling, increased saliva, progression of colorectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, bleeding, elevated cholesterol, tinnitus, chills, buttock pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, weakness, fever, edema, rigidity, syncope, congestive heart failure, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, multiple organ failure, intentional overdose, chest discomfort, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, urticaria, rash, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory tract syndrome, lip swelling, agitation, neuroexcitation, hyperactivity, gastrointestinal symptoms, respiratory depression, drowsiness, coma, cardiac arrest, QT prolongation, liver failure, coagulopathy, abdominal discomfort, lethargy, pallor, hyperhidrosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and it is recommended to keep it at room temperature between 1°C and 30°C. This storage method helps maintain the effectiveness of the medication and prevents deterioration.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.